189 related articles for article (PubMed ID: 19279002)
21. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.
Cullinan SB; Gordan JD; Jin J; Harper JW; Diehl JA
Mol Cell Biol; 2004 Oct; 24(19):8477-86. PubMed ID: 15367669
[TBL] [Abstract][Full Text] [Related]
22. Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells.
Baird L; Dinkova-Kostova AT
Biochem Biophys Res Commun; 2013 Mar; 433(1):58-65. PubMed ID: 23454126
[TBL] [Abstract][Full Text] [Related]
23. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
[TBL] [Abstract][Full Text] [Related]
24. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
25. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
Zhang DD; Lo SC; Cross JV; Templeton DJ; Hannink M
Mol Cell Biol; 2004 Dec; 24(24):10941-53. PubMed ID: 15572695
[TBL] [Abstract][Full Text] [Related]
26. Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
Martinez VD; Vucic EA; Pikor LA; Thu KL; Hubaux R; Lam WL
Mol Cancer; 2013 Oct; 12(1):124. PubMed ID: 24138990
[TBL] [Abstract][Full Text] [Related]
27. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
Sekhar KR; Rachakonda G; Freeman ML
Toxicol Appl Pharmacol; 2010 Apr; 244(1):21-6. PubMed ID: 19560482
[TBL] [Abstract][Full Text] [Related]
28. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.
Furukawa M; Xiong Y
Mol Cell Biol; 2005 Jan; 25(1):162-71. PubMed ID: 15601839
[TBL] [Abstract][Full Text] [Related]
29. Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2.
McMahon M; Swift SR; Hayes JD
Toxicol Appl Pharmacol; 2018 Dec; 360():45-57. PubMed ID: 30261176
[TBL] [Abstract][Full Text] [Related]
30. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
Ichikawa T; Li J; Meyer CJ; Janicki JS; Hannink M; Cui T
PLoS One; 2009 Dec; 4(12):e8391. PubMed ID: 20027226
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.
Niture SK; Jain AK; Jaiswal AK
J Cell Sci; 2009 Dec; 122(Pt 24):4452-64. PubMed ID: 19920073
[TBL] [Abstract][Full Text] [Related]
32. Nuclear import and export signals in control of Nrf2.
Jain AK; Bloom DA; Jaiswal AK
J Biol Chem; 2005 Aug; 280(32):29158-68. PubMed ID: 15901726
[TBL] [Abstract][Full Text] [Related]
33. Fuzzy complex formation between the intrinsically disordered prothymosin α and the Kelch domain of Keap1 involved in the oxidative stress response.
Khan H; Cino EA; Brickenden A; Fan J; Yang D; Choy WY
J Mol Biol; 2013 Mar; 425(6):1011-27. PubMed ID: 23318954
[TBL] [Abstract][Full Text] [Related]
34. p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.
Tao S; Liu P; Luo G; Rojo de la Vega M; Chen H; Wu T; Tillotson J; Chapman E; Zhang DD
Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28115426
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
Kobayashi A; Kang MI; Okawa H; Ohtsuji M; Zenke Y; Chiba T; Igarashi K; Yamamoto M
Mol Cell Biol; 2004 Aug; 24(16):7130-9. PubMed ID: 15282312
[TBL] [Abstract][Full Text] [Related]
36. Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.
Tsai YS; Jou YC; Tsai HT; Shiau AL; Wu CL; Tzai TS
Cancer Sci; 2019 Apr; 110(4):1208-1219. PubMed ID: 30719818
[TBL] [Abstract][Full Text] [Related]
37. Structural analysis of the complex of Keap1 with a prothymosin alpha peptide.
Padmanabhan B; Nakamura Y; Yokoyama S
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Apr; 64(Pt 4):233-8. PubMed ID: 18391415
[TBL] [Abstract][Full Text] [Related]
38. [Influence of prothymosin alpha and its mutants on activity of the p53 tumor suppressor].
Zakharova NI; Sokolov VV; Rud'ko VV; Mel'nikov SV; Vartapetian AB; Evstaf'eva AG
Mol Biol (Mosk); 2008; 42(4):673-84. PubMed ID: 18856068
[TBL] [Abstract][Full Text] [Related]
39. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex.
McMahon M; Thomas N; Itoh K; Yamamoto M; Hayes JD
J Biol Chem; 2006 Aug; 281(34):24756-68. PubMed ID: 16790436
[TBL] [Abstract][Full Text] [Related]
40. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]